

Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., shares update on Tetra’s Cannabinoid-based drug pipeline as opioid alternative.
Investor Presentation Deck
Tetra Investor Presentation


Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., shares update on Tetra’s Cannabinoid-based drug pipeline as opioid alternative.
Investor Presentation Deck
Tetra Investor Presentation
VANCOUVER, Washington, Oct. 01, 2019– CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today FDA clearance […]
Beauty and Wellness Experience for Successful Global Brands, Creativity, and Strategic Acumen Determined the Successful Agency Selection VANCOUVER, British Columbia, April 04, 2019 – The Yield Growth Corp. (CSE: BOSS) (OTC: BOSQF) (frankfurt:YG3) announces The Design […]
FSD Pharma Announces Strategic Investment in Huge Shops – Huge Shops forms alliance with Coffee Time’s parent company Chairman’s Brands to establish retail distribution network – TORONTO—FSD Pharma Inc. (“FSD Pharma” or “FSD”) (CSE: HUGE) (OTCQB: […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
